Walleye Capital’s Mesa Laboratories MLAB Stock Holding History

Walleye Capital’s Portfolio MLAB Stock Details MLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,864	Closed	-$314K	–	5825
2024 Q1	$314K	Buy	+2,864	New	+$289K	﹤0.01%	3625

Other funds holding MLAB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Walleye Capital's MLAB Position: Q2 2024 in Review

Walleye Capital sold out of Mesa Laboratories (MLAB) in Q2 2024, closing a stake of 2,864 shares — an estimated $314K sold.

Walleye Capital first reported a position in MLAB in Q1 2024 and held it in 1 quarter. The position peaked at $314K in Q1 2024. 154 funds tracked by Wall St. Rank hold MLAB as of Q2 2024.

Walleye Capital reported no remaining Mesa Laboratories position as of Q2 2024 after selling out during the quarter.
Walleye Capital sold 2,864 Mesa Laboratories shares in Q2 2024, an estimated $314K.
Walleye Capital first reported a position in Mesa Laboratories in Q1 2024 and held it in 1 quarter.
Walleye Capital's Mesa Laboratories position peaked at $314K in Q1 2024.
154 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2024.

Based on Walleye Capital's 13F filing for Q2 2024, filed 14 Aug 2024.